Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Am J Trop Med Hyg ; 2022 Aug 08.
Article in English | MEDLINE | ID: mdl-35940199

ABSTRACT

Hymenopteran venoms, inoculated during stings by ants, bees, and wasps, are the most frequent cause of an IgE-mediated systemic hypersensitivity reaction in adults, which is a key process in drastic manifestations of anaphylaxis. Respiratory involvement is usually caused by pulmonary edema but is rarely described as including interstitial pneumonitis or acute respiratory distress syndrome. Here, we describe a case of severe allergic reaction after a sting by Apoica pallens with late-onset pulmonary involvement, including signs of vasoplegia (pleural effusion) and interstitial pneumonitis with mild rhabdomyolysis. The presence of late onset of pulmonary involvement after a severe allergic reaction after a sting by A. pallens shows the importance of keeping a patient with severe reactions under medical care for a minimum of 5 days to avoid serious late complications outside the hospital environment.

2.
J Trop Pediatr ; 67(4)2021 08 27.
Article in English | MEDLINE | ID: mdl-34545404

ABSTRACT

An increasing number of reports have described human parvovirus B19 infection in association with a variety of neurological manifestations, especially in children. This study assessed the clinical and laboratory outcomes found in a case series of immunocompetent children who tested positive for parvovirus B19 by qualitative polymerase chain reaction assays of cerebrospinal fluid, in a tertiary referral center in the western Brazilian Amazon. We screened 178 children with clinically diagnosed central nervous system infections (meningoencephalitis). Of these, five (2.8%) were positive for parvovirus B19. A literature review also presented herein identified a further 50 cases of parvovirus B19 with neurological manifestations. Thus, even if the classic signs of parvovirus B19 infection are absent, such as the well-known rash, children with signs of neurological infection should also be evaluated for parvovirus B19 infection.


Subject(s)
Erythema Infectiosum , Nervous System Diseases , Parvoviridae Infections , Parvovirus B19, Human , Child , Erythema Infectiosum/diagnosis , Humans , Parvoviridae Infections/complications , Parvoviridae Infections/diagnosis , Polymerase Chain Reaction
4.
Clin Infect Dis ; 72(9): e373-e381, 2021 05 04.
Article in English | MEDLINE | ID: mdl-32785710

ABSTRACT

BACKGROUND: Steroid use for coronavirus disease 2019 (COVID-19) is based on the possible role of these drugs in mitigating the inflammatory response, mainly in the lungs, triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to evaluate the efficacy of methylprednisolone (MP) among hospitalized patients with suspected COVID-19. METHODS: A parallel, double-blind, placebo-controlled, randomized, Phase IIb clinical trial was performed with hospitalized patients aged ≥18 years with clinical, epidemiological, and/or radiological suspected COVID-19 at a tertiary care facility in Manaus, Brazil. Patients were randomly allocated (1:1 ratio) to receive either intravenous MP (0.5 mg/kg) or placebo (saline solution) twice daily for 5 days. A modified intention-to-treat (mITT) analysis was conducted. The primary outcome was 28-day mortality. RESULTS: From 18 April to 16 June 2020, 647 patients were screened, 416 were randomized, and 393 were analyzed as mITT, with 194 individuals assigned to MP and 199 to placebo. SARS-CoV-2 infection was confirmed by reverse transcriptase polymerase chain reaction in 81.3%. The mortality rates at Day 28 were not different between groups. A subgroup analysis showed that patients over 60 years old in the MP group had a lower mortality rate at Day 28. Patients in the MP arm tended to need more insulin therapy, and no difference was seen in virus clearance in respiratory secretion until Day 7. CONCLUSIONS: The findings of this study suggest that a short course of MP in hospitalized patients with COVID-19 did not reduce mortality in the overall population. CLINICAL TRIALS REGISTRATION: NCT04343729.


Subject(s)
COVID-19 , Adolescent , Adult , Brazil , Double-Blind Method , Humans , Methylprednisolone/therapeutic use , Middle Aged , SARS-CoV-2 , Treatment Outcome
5.
Am J Trop Med Hyg ; 103(4): 1604-1607, 2020 10.
Article in English | MEDLINE | ID: mdl-32876012

ABSTRACT

Although high mortality has been reported in many COVID-19 studies, very limited postmortem information from complete autopsies is available. We report the findings in the adrenal glands in 28 autopsies with confirmed SARS-CoV-2 infection. Microscopic lesions were identified in the adrenal glands in 12/28 patients (46%). Seven cases showed necrosis, generally ischemic; four showed cortical lipid degeneration; two showed hemorrhage; and one unspecific focal adrenalitis. Vascular thrombosis in one patient and focal inflammation in association with other findings in three patients were observed. No case presented adrenal insufficiency. In conclusion, adrenal lesions are frequent in patients with severe COVID-19. The lesions are mild but could contribute to the lethal outcome.


Subject(s)
Adrenal Glands/pathology , Autopsy/standards , Betacoronavirus , Coronavirus Infections/pathology , Pneumonia, Viral/pathology , Adult , Aged , Autopsy/methods , COVID-19 , Female , Humans , Hydrocortisone/blood , Male , Middle Aged , Pandemics , SARS-CoV-2
7.
Am J Trop Med Hyg ; 86(4): 732-5, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22492162

ABSTRACT

Oropouche fever is the second most frequent arboviral infection in Brazil, surpassed only by dengue. Oropouche virus (OROV) causes large and explosive outbreaks of acute febrile illness in cities and villages in the Amazon and Central-Plateau regions. Cerebrospinal fluid (CSF) samples from 110 meningoencephalitis patients were analyzed. The RNA extracted from fluid was submitted to reverse transcription-polymerase chain reaction and sequencing to identify OROV. Three CSF samples showed the presence of OROV causing infection in the central nervous system (CNS). These patients are adults. Two of the patients had other diseases affecting CNS and immune systems: neurocysticercosis and acquired immunodeficiency syndrome, respectively. Nucleotide sequence analysis showed that the OROV from the CSF of these patients belonged to genotype I. We show here that severe Oropouche disease is occurring during outbreaks of this virus in Brazil.


Subject(s)
Bunyaviridae Infections/cerebrospinal fluid , Disease Outbreaks , Genome, Viral , Meningoencephalitis/cerebrospinal fluid , Orthobunyavirus/isolation & purification , Adult , Brazil/epidemiology , Bunyaviridae Infections/epidemiology , Dengue/cerebrospinal fluid , Dengue/epidemiology , Female , Genotype , Humans , Male , Meningoencephalitis/epidemiology , Middle Aged , Orthobunyavirus/genetics , Orthobunyavirus/pathogenicity , Reverse Transcriptase Polymerase Chain Reaction , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...